Medifast, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 1,072.05 million compared to USD 1,598.58 million a year ago. Net income was USD 99.42 million compared to USD 143.57 million a year ago.

Basic earnings per share from continuing operations was USD 9.13 compared to USD 12.82 a year ago. Diluted earnings per share from continuing operations was USD 9.1 compared to USD 12.73 a year ago.